Walleye Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.4K Sell
2,700
-16,300
-86% -$229K ﹤0.01% 4213
2026
Q1
$226K Buy
19,000
+11,800
+164% +$169K ﹤0.01% 3263
2025
Q4
$111K Buy
+7,200
New +$132K ﹤0.01% 3828
2025
Q3
Sell
-3,200
Closed -$71.1K 5068
2025
Q2
$71.1K Buy
+3,200
New +$71.1K ﹤0.01% 3918
2023
Q4
Sell
-1,500
Closed -$43.9K 5457
2023
Q3
$43.9K Buy
+1,500
New +$53.9K ﹤0.01% 4225

Other funds holding SGRY

Walleye Capital's SGRY Position: Q2 2026 in Review

Walleye Capital increased its Surgery Partners (SGRY) stake by 12% in Q2 2026, buying an estimated $5.15K and bringing the position to 3,529 shares worth $59.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4121.

Walleye Capital first reported a position in SGRY in Q3 2021 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2024. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Walleye Capital held 3,529 shares of Surgery Partners worth $59.3K as of Q2 2026.
  • Walleye Capital bought 367 Surgery Partners shares in Q2 2026, an estimated $5.15K.
  • Surgery Partners made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4121 holding.
  • Walleye Capital first reported a position in Surgery Partners in Q3 2021 and has held it in 13 quarters since.
  • Walleye Capital's Surgery Partners position peaked at $16.1M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.